CUR Trade on Dec 5, 2017 15:45 from konradengen: Tradervue User Stock Trades.

Bought this biotech stock in the late afternoon. Thesis was that it could squeeze shorts as the biotech sector heated up a little. It broke HOD, and when it re-broke out again I took a position right above NHOD. I was risking at 2.39, and goal was to sell at 2.90, as it had some resistance there back from July. My trade plan worked, and it was a decent trade. The pattern was good. Me following my plan was good. And my entry was good. Altough it is easy to see hindsight, it would probably have been better to keep a tighter risk, as I only was looking for some squeezing into the Close. It turns out the RR-ratio was only slightly better than 1/1, when considering some slippage on the exit. A better risk would probably have been 2.45. 2.39 would perhaps been a better risk if I was looking for a bigger Picture move. I also could have been more aggressive With my goal(s). The ideal scenario would have been to Lock half around 2.90, and Lock the rest Close to 3.25, as it had some warrants there. But it does not make a lot of sense to scale out, when I play this small size. Still taking away a positive experience from this trade, which is the first one in quite a while.